Advanced Search
Disease Phase
Title Drug
Clinical Trials Listing
  • < Previous
  • 1
  • Next >
  • Penn Treatment Trials (5)
  • Penn Non-Treatment Trials (6)
  • Phase 1: Solid Tumor Trials (3)
  • Proton Therapy Trials (2)
Active treatment trials at Penn's Abramson Cancer Center
Protocol ID Title Phase Modality Drug
CALGB-90601 A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients With Advanced Transitional Cell Carcinoma III Angiogenesis Inhibitor, Chemotherapy cisplatin; gemcitabine; bevacizumab
11D.392 A Phase II Study of Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy II Chemotherapy, Colony Stimulating Factor Therapy, Blood Test pegfilgrastim; cabazitaxel
UPCC 19811 Feasibility and Phase 1/II Trial of Adjuvant Radiation Therapy for the Treatment of Urothelial Bladder Cancer Using Proton Therapy or IMRT I / II Radiotherapy, Proton Therapy Not Applicable
AEZS-108-046 A Phase I/II Trial of AEZS-108 in Locally Advanced Unresectable or Metastatic Luteinizing Hormone-releasing Hormone(LHRH) Positive Urothelial Carcinoma Patients Who Failed Platinum Based Chemotherapy I / II Biological Therapy zoptarelin doxorubicin
CA186-011 A Phase 1 Study of the Safety, Tolerability, Pharmacokinetics and Immunoregulatory Activity of BMS-663513 (Anti-CD137) in Subjects With Advanced and/or Metastatic Solid Tumors I Immunotherapy BMS-663513
Displaying: 1 - 5 of 5 Results
  • < Previous
  • 1
  • Next >